MedPath

The Safe-line Technique as Additional Attempt to Mitigate Spinal Cord Ischemia After Endovascular Exclusion of TAAA

Recruiting
Conditions
Thoracoabdominal Aortic Aneurysm
Registration Number
NCT05758844
Lead Sponsor
University Hospital Padova
Brief Summary

To assess safety and feasebility of the "safe-line" technique in a multicenter international collaboration.

Detailed Description

To assess safety and efficacy of a technique for temporary aneurysm sac re-perfusion (TASreP) after total endovascular exclusion of TAAA, using a guide-wire left into the aneurysm sac. The technique can be applied both in elective that urgent cases.

The guide-wire aim to be a "safe-line" for fast temporary trans-sealing aneurysm sac re-perfusion in case of SCI occurring in the early post-operative period (48-to 72h).

Before completing exclusion, from the percutaneous femoral access, a second buddy-wire (V-18 guidewire; Boston Scientific) is advanced and left posterior to the endograft into the aneurysmal sac; through the main guide-wire, the final aneurysm exclusion is completed with distal stent-graft deployment and the femoral access sealed with Proglide leaving in place the sole V.018 draped in a sterile fashion. In the case of SCI occurrence in the post-operative period up to 48-72 hrs, the trans-sealing V.18 "safe-line" can be rapidly exchanged with a 6F/65 cm long Destination cm guiding sheath (Terumo) and positioned into the aneurysmal sac; this can be connected to a 6F introducer from the contralateral femoral artery and the sac perfused in a retrograde fashion.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Thoraco-abdominal aortic aneurysm including type I,II,III,IV and V.
  • Pararenale aneurysm
  • Thoracoabdominal aortic aneurysm Elective and Urgent, endovascular repair;
  • Endovascular repair of any thoracoabdominal aortic condition
Read More
Exclusion Criteria

-thoraco-abdominal aortic aneurysm open repair

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of adverse events7 days

collect eventual complications (incidence of: 1- axis thrombosis; 2- microembolization; 3-hematoma)

Incidence of spinal cord ischemia improvement or resolution30 days

collect all events that in case of post-operative (48-72hrs) spinal cord ischemia had symptoms mitigation (1-paraplegia improvement; 2 - paraplegia complete resolution)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vascular and Endovascular Clinic - Padova University

🇮🇹

Padova, Italy

© Copyright 2025. All Rights Reserved by MedPath